Upgrade to SI Premium - Free Trial

BioMarin Pharma (BMRN) Will Seek Review of PTAB Exon 51 Composition of Matter Patent Decision (SRPT)

September 21, 2016 8:55 AM
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that it intends to seek a review of the Patent Trial and Appeal Board ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Litigation

Next Articles